Bausch Health To Appeal Expected Court Decision On Xifaxan Patents
- ByBenzinga-
Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin). The company shares gained a...